iBio posts $33M net loss in fiscal 2026 as R&D spending surges

Go back to iBio posts $33M net loss in fiscal 2026 as R&D spending surges
IBIO, Inc. (NASDAQ: IBIO) Delayed: 0.77 --0 (-0%)
Previous Close $0.77    52 Week High $0.80 
Open $0.77    52 Week Low $0.34 
Day High $0.77    P/E N/A 
Day Low $0.77    EPS $-0.08 
Volume 8